Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18782641 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Exenatide once weekly (BYDUREON™)
2 Completed
Has Results
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide, long acting release;   Drug: exenatide

Study has passed its completion date and status has not been verified in more than two years.